Volume Overload Profiles in Patients With Preserved and Reduced Ejection Fraction Chronic Heart Failure Are There Differences? A Pilot Study

被引:62
|
作者
Miller, Wayne L. [1 ]
Mullan, Brian P. [2 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Div Diagnost Radiol Nucl Med, Rochester, MN USA
关键词
decompensated chronic heart failure; diuretic therapy; HFpEF; HFrEF; total blood volume quantitation; volume overload; BLOOD-VOLUME; SODIUM; HEMODILUTION; ANEMIA; WATER;
D O I
10.1016/j.jchf.2016.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study aimed to characterize volume profiles and their differences in heart failure (HF) patients with preserved (HFpEF) and reduced (HFrEF) ventricular systolic function. BACKGROUND The extent and distribution of volume overload and the associated implications for volume management have not been studied in decompensated HFpEF compared with HFrEF. METHODS Total blood volume (TBV) was quantitated using a standardized computer-based radiolabeled albumin dilution technique. RESULTS Twenty HFpEF and 35 HFrEF patients were evaluated at hospital admission. TBV was expanded by 27 21% (range-5.2% to 77%; p = 0.002) and 37 +/- 25% (0% to 107%; p < 0.001), respectively, above normal volumes. Red cell mass (RBCM) was expanded in HFrEF (24 +/- 31%; p = 0.004) but within normal limits in HFpEF (8 +/- 34%; p = 0.660) with, however, large variability in both groups. RBCM excess was more prominent in HFrEF (63% vs. 45%) than the RBCM deficit in HFpEF (35% vs.14%). With diuresis, TBV decreased to 25 +/- 20% (p = 0.029) in HFrEF but was not changed in HFpEF (18 +/- 20% [p = 0.173]). Body weight declined 6.6 +/- 4.4 kg in HFrEF and 10.5 +/- 8.3 kg (p = 0.026) in HFpEF. Interstitial fluid losses accounted for 85 +/- 13% (HFrEF) and 93 +/- 6% (HFpEF) (p = 0.012) of total volume removed. CONCLUSIONS TBV profiles differ between HFpEF and HFrEF patients with DCHF. Quantitated volume analysis revealed both significant RBCM (polycythemia) and plasma volume excess in HFrEF, whereas a higher RBCM deficit (true anemia) was demonstrated in HFpEF. Diuresis produced only a modest reduction in intravascular volumes with persistent hypervolemia in both groups at discharge, but overall more total body fluid was lost in HFpEF. These profile differences have implications for individualizing volume management. (C) 2016 by the American College of Cardiology Foundation.
引用
收藏
页码:453 / 459
页数:7
相关论文
共 50 条
  • [1] Pressure-volume Profiles In Heart Failure With Reduced Ejection Fraction And Heart Failure With Preserved Ejection Fraction
    Kittipibul, Veraprapas
    Yaranov, Dmitry
    Rao, Vishal
    Jefferies, John
    Silver, Marc A.
    Fudim, Marat
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 603 - 603
  • [2] Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
    Tromp, Jasper
    Khan, Mohsin A. F.
    Klip, IJsbrand T.
    Meyer, Sven
    de Boer, Rudolf A.
    Jaarsma, Tiny
    Hillege, Hans
    van Veldhuisen, Dirk J.
    van der Meer, Peter
    Voors, Adriaan A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04):
  • [3] BIOMARKER PROFILES IN HEART FAILURE PATIENTS WITH A PRESERVED AND REDUCED EJECTION FRACTION
    Tromp, Jasper
    Klip, IJsbrand
    Meyer, Sven
    De Boer, Rudolf
    Jaarsma, Tiny
    Hillege, Hans
    van Veldhuisen, Dirk
    Voors, Adriaan
    Vandermeer, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A991 - A991
  • [4] Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Sattar, Naveed
    Brueckmann, Martina
    Jamal, Waheed
    Cotton, Daniel
    Iwata, Tomoko
    Zannad, Faiez
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (11) : 1381 - 1392
  • [5] Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction
    Chiorescu, Roxana Mihaela
    Lazar, Roxana-Daiana
    Buksa, Sandor-Botond
    Mocan, Mihaela
    Blendea, Dan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [6] Regarding clinical profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction
    Chen, Yan
    Yang, Xin-Hua
    Cheng, Yuan-Lin
    Zhou, Qing
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 423
  • [7] Clinical and proteomic profiles of chronic kidney disease in heart failure with preserved and reduced ejection fraction
    Voordes, Gerhard Hendrik Dirk
    Damman, K.
    Hoegl, A.
    Madsen, C. T.
    Van Essen, B. J.
    Ouwerkerk, W.
    Tromp, J.
    Gronborg, M.
    Refgaard, J. C.
    Lang, C. C.
    Barascuk-Michaelsen, N.
    Voors, A. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 186 - 187
  • [8] Clinical and proteomic profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction
    Voordes, Geert H. D.
    Voors, Adriaan A.
    Hoegl, Annabelle
    Madsen, Christian T.
    van Essen, Bart J.
    Ouwerkerk, Wouter
    Tromp, Jasper
    de la Rambelje, Mark A.
    Gronborg, Mads
    Refsgaard, Jan C.
    Lang, Chim C.
    Barascuk-Michaelsen, Natasha
    Damman, Kevin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
  • [9] Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction
    Pandey, Ambarish
    Omar, Wally
    Ayers, Colby
    LaMonte, Michael
    Klein, Liviu
    Allen, Norrina B.
    Kuller, Lewis H.
    Greenland, Philip
    Eaton, Charles B.
    Gottdiener, John S.
    Lloyd-Jones, Donald M.
    Berry, Jarett D.
    CIRCULATION, 2018, 137 (17) : 1814 - +
  • [10] Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study
    Silvestrini, Andrea
    Bruno, Carmine
    Vergani, Edoardo
    Venuti, Angela
    Favuzzi, Angela Maria Rita
    Guidi, Francesco
    Nicolotti, Nicola
    Meucci, Elisabetta
    Mordente, Alvaro
    Mancini, Antonio
    PLOS ONE, 2019, 14 (01):